Last 12 months
Inside the activity.
0 purchase rows · 80 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 10 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 8 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 7 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 5 |
| Aug 2026 | 0 | 9 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 7 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 10, 2026 Filed Jul 15, 2026 01:21 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
Exercise / conversionCommon Stock | 56,122 | $2.42 | $135,815.24 |
DisclosureSEC source: 0001628280-26-048229 · wk-form4_1784078490.xml · nonDerivative · entry 1 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 975,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2026 Filed Jul 3, 2026 01:05 UTC |
O CONNOR KEVIN JDirector
|
SaleCommon Stock | 4,072 | $42.99 | $175,055.28 |
DisclosureSEC source: 0001628280-26-047090 · wk-form4_1783040708.xml · nonDerivative · entry 3 O CONNOR KEVIN J · CIK 0001106321 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 962,132 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated March 13, 2026. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $42.76 to $43.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held by the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19. Read SEC document |
| July 02, 2026 Filed Jul 3, 2026 01:05 UTC |
O CONNOR KEVIN JDirector
|
SaleCommon Stock | 1,697 | $42.40 | $71,952.80 |
DisclosureSEC source: 0001628280-26-047090 · wk-form4_1783040708.xml · nonDerivative · entry 2 O CONNOR KEVIN J · CIK 0001106321 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 966,204 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated March 13, 2026. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $41.74 to $42.735, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held by the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19. Read SEC document |
| July 01, 2026 Filed Jul 3, 2026 01:05 UTC |
O CONNOR KEVIN JDirector
|
SaleCommon Stock | 5,769 | $41.93 | $241,894.17 |
DisclosureSEC source: 0001628280-26-047090 · wk-form4_1783040708.xml · nonDerivative · entry 1 O CONNOR KEVIN J · CIK 0001106321 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 967,901 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated March 13, 2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $41.82 to $42.115, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held by the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 01:33 UTC |
O CONNOR KEVIN JDirector
|
SaleCommon Stock | 5,769 | $42.00 | $242,298.00 |
DisclosureSEC source: 0001628280-26-044095 · wk-form4_1781746415.xml · nonDerivative · entry 3 O CONNOR KEVIN J · CIK 0001106321 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 973,670 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated March 13, 2026. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $41.70 to $42.235, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held by the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 01:33 UTC |
O CONNOR KEVIN JDirector
|
SaleCommon Stock | 117 | $43.26 | $5,060.84 |
DisclosureSEC source: 0001628280-26-044095 · wk-form4_1781746415.xml · nonDerivative · entry 2 O CONNOR KEVIN J · CIK 0001106321 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 979,439 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated March 13, 2026. F3 · ownership.nature: These shares are held by the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 01:33 UTC |
O CONNOR KEVIN JDirector
|
SaleCommon Stock | 5,658 | $42.91 | $242,784.78 |
DisclosureSEC source: 0001628280-26-044095 · wk-form4_1781746415.xml · nonDerivative · entry 1 O CONNOR KEVIN J · CIK 0001106321 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 979,556 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated March 13, 2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $42.23 to $43.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held by the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19. Read SEC document |
| June 12, 2026 Filed Jun 13, 2026 01:58 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
PurchasePut Option (Right to Sell) · Derivative | 2 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001805735-26-000004 · form4-06132026_010620.xml · derivative · entry 10 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 2 Underlying: Common Stock · 1,700,000 shares Expires not disclosed F8 · derivative.exercise_price: On June 12, 2026, the Family Trust and the 2021 Trust (collectively, "Holders") executed revolving loan and collar transactions with an unaffiliated bank (collectively, the "Transaction") for general liquidity purposes, pursuant to which European call options were written and European put options were purchased relating to an aggregate of 1,700,000 shares (1,190,000 shares for the Family Trust and 510,000 shares for the 2021 Trust) and the underlying shares were pledged to the bank to secure the Holders' obligations thereunder. The Transaction is divided into 10 equal components across each trust, that have expiration dates ranging from June 1, 2029 to June 14, 2029, both inclusive. F9 · derivative.exercise_price: On the relevant expiration date, the call option will automatically be exercised (and the put option will expire unexercised) if the volume weighted average price of the shares of Common Stock on the relevant expiration date (the "Reference Price") is greater than or equal to the call option strike price; the put option will automatically be exercised (and the call option will expire unexercised) if the Reference Price is less than or equal to the put option strike price; and the call option and the put option will each expire unexercised if the Reference Price is greater than the put option strike price but less than the call option strike price. F10 · derivative.exercise_price: For each component, on the applicable settlement date, the applicable Holder will deliver the number of shares corresponding to such component to the bank (or, at such Holder's election, an equivalent amount of cash based on the Reference Price), and receive from the bank an amount of cash (if any) based on the terms of the Transaction. No premium was exchanged for either the call option or the put option. The Holders will be permitted to draw against each component prior to its expiration in accordance with the terms of the Transaction. The Holders generally retained voting and dividend rights over the pledged shares during the term of the pledge, subject to sharing with the bank the economic benefit of any dividends paid during the term of the pledge based on a formula that takes into account a theoretical offsetting position by the bank. F12 · derivative.exercise_price: Exercise price of $37.5716 per share. F8 · kind: On June 12, 2026, the Family Trust and the 2021 Trust (collectively, "Holders") executed revolving loan and collar transactions with an unaffiliated bank (collectively, the "Transaction") for general liquidity purposes, pursuant to which European call options were written and European put options were purchased relating to an aggregate of 1,700,000 shares (1,190,000 shares for the Family Trust and 510,000 shares for the 2021 Trust) and the underlying shares were pledged to the bank to secure the Holders' obligations thereunder. The Transaction is divided into 10 equal components across each trust, that have expiration dates ranging from June 1, 2029 to June 14, 2029, both inclusive. F9 · kind: On the relevant expiration date, the call option will automatically be exercised (and the put option will expire unexercised) if the volume weighted average price of the shares of Common Stock on the relevant expiration date (the "Reference Price") is greater than or equal to the call option strike price; the put option will automatically be exercised (and the call option will expire unexercised) if the Reference Price is less than or equal to the put option strike price; and the call option and the put option will each expire unexercised if the Reference Price is greater than the put option strike price but less than the call option strike price. F10 · kind: For each component, on the applicable settlement date, the applicable Holder will deliver the number of shares corresponding to such component to the bank (or, at such Holder's election, an equivalent amount of cash based on the Reference Price), and receive from the bank an amount of cash (if any) based on the terms of the Transaction. No premium was exchanged for either the call option or the put option. The Holders will be permitted to draw against each component prior to its expiration in accordance with the terms of the Transaction. The Holders generally retained voting and dividend rights over the pledged shares during the term of the pledge, subject to sharing with the bank the economic benefit of any dividends paid during the term of the pledge based on a formula that takes into account a theoretical offsetting position by the bank. F8 · price: On June 12, 2026, the Family Trust and the 2021 Trust (collectively, "Holders") executed revolving loan and collar transactions with an unaffiliated bank (collectively, the "Transaction") for general liquidity purposes, pursuant to which European call options were written and European put options were purchased relating to an aggregate of 1,700,000 shares (1,190,000 shares for the Family Trust and 510,000 shares for the 2021 Trust) and the underlying shares were pledged to the bank to secure the Holders' obligations thereunder. The Transaction is divided into 10 equal components across each trust, that have expiration dates ranging from June 1, 2029 to June 14, 2029, both inclusive. F9 · price: On the relevant expiration date, the call option will automatically be exercised (and the put option will expire unexercised) if the volume weighted average price of the shares of Common Stock on the relevant expiration date (the "Reference Price") is greater than or equal to the call option strike price; the put option will automatically be exercised (and the call option will expire unexercised) if the Reference Price is less than or equal to the put option strike price; and the call option and the put option will each expire unexercised if the Reference Price is greater than the put option strike price but less than the call option strike price. F10 · price: For each component, on the applicable settlement date, the applicable Holder will deliver the number of shares corresponding to such component to the bank (or, at such Holder's election, an equivalent amount of cash based on the Reference Price), and receive from the bank an amount of cash (if any) based on the terms of the Transaction. No premium was exchanged for either the call option or the put option. The Holders will be permitted to draw against each component prior to its expiration in accordance with the terms of the Transaction. The Holders generally retained voting and dividend rights over the pledged shares during the term of the pledge, subject to sharing with the bank the economic benefit of any dividends paid during the term of the pledge based on a formula that takes into account a theoretical offsetting position by the bank. F8 · derivative.exercise_date: On June 12, 2026, the Family Trust and the 2021 Trust (collectively, "Holders") executed revolving loan and collar transactions with an unaffiliated bank (collectively, the "Transaction") for general liquidity purposes, pursuant to which European call options were written and European put options were purchased relating to an aggregate of 1,700,000 shares (1,190,000 shares for the Family Trust and 510,000 shares for the 2021 Trust) and the underlying shares were pledged to the bank to secure the Holders' obligations thereunder. The Transaction is divided into 10 equal components across each trust, that have expiration dates ranging from June 1, 2029 to June 14, 2029, both inclusive. F9 · derivative.exercise_date: On the relevant expiration date, the call option will automatically be exercised (and the put option will expire unexercised) if the volume weighted average price of the shares of Common Stock on the relevant expiration date (the "Reference Price") is greater than or equal to the call option strike price; the put option will automatically be exercised (and the call option will expire unexercised) if the Reference Price is less than or equal to the put option strike price; and the call option and the put option will each expire unexercised if the Reference Price is greater than the put option strike price but less than the call option strike price. F10 · derivative.exercise_date: For each component, on the applicable settlement date, the applicable Holder will deliver the number of shares corresponding to such component to the bank (or, at such Holder's election, an equivalent amount of cash based on the Reference Price), and receive from the bank an amount of cash (if any) based on the terms of the Transaction. No premium was exchanged for either the call option or the put option. The Holders will be permitted to draw against each component prior to its expiration in accordance with the terms of the Transaction. The Holders generally retained voting and dividend rights over the pledged shares during the term of the pledge, subject to sharing with the bank the economic benefit of any dividends paid during the term of the pledge based on a formula that takes into account a theoretical offsetting position by the bank. F8 · derivative.expiration_date: On June 12, 2026, the Family Trust and the 2021 Trust (collectively, "Holders") executed revolving loan and collar transactions with an unaffiliated bank (collectively, the "Transaction") for general liquidity purposes, pursuant to which European call options were written and European put options were purchased relating to an aggregate of 1,700,000 shares (1,190,000 shares for the Family Trust and 510,000 shares for the 2021 Trust) and the underlying shares were pledged to the bank to secure the Holders' obligations thereunder. The Transaction is divided into 10 equal components across each trust, that have expiration dates ranging from June 1, 2029 to June 14, 2029, both inclusive. F9 · derivative.expiration_date: On the relevant expiration date, the call option will automatically be exercised (and the put option will expire unexercised) if the volume weighted average price of the shares of Common Stock on the relevant expiration date (the "Reference Price") is greater than or equal to the call option strike price; the put option will automatically be exercised (and the call option will expire unexercised) if the Reference Price is less than or equal to the put option strike price; and the call option and the put option will each expire unexercised if the Reference Price is greater than the put option strike price but less than the call option strike price. F10 · derivative.expiration_date: For each component, on the applicable settlement date, the applicable Holder will deliver the number of shares corresponding to such component to the bank (or, at such Holder's election, an equivalent amount of cash based on the Reference Price), and receive from the bank an amount of cash (if any) based on the terms of the Transaction. No premium was exchanged for either the call option or the put option. The Holders will be permitted to draw against each component prior to its expiration in accordance with the terms of the Transaction. The Holders generally retained voting and dividend rights over the pledged shares during the term of the pledge, subject to sharing with the bank the economic benefit of any dividends paid during the term of the pledge based on a formula that takes into account a theoretical offsetting position by the bank. F4 · ownership.nature: These securities are held by the Craig F. Courtemanche and Hillary Courtemanche Family Trust dated as of November 1, 2012 ("Family Trust"). F5 · ownership.nature: These securities are held by the Courtemanche 2021 Irrevocable Trust UA DTD 6/10/2021 ("2021 Trust"). Read SEC document |
| June 12, 2026 Filed Jun 13, 2026 01:58 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
SaleCall Option (Obligation to Sell) · Derivative | 2 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001805735-26-000004 · form4-06132026_010620.xml · derivative · entry 9 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 2 Underlying: Common Stock · 1,700,000 shares Expires not disclosed F8 · derivative.exercise_price: On June 12, 2026, the Family Trust and the 2021 Trust (collectively, "Holders") executed revolving loan and collar transactions with an unaffiliated bank (collectively, the "Transaction") for general liquidity purposes, pursuant to which European call options were written and European put options were purchased relating to an aggregate of 1,700,000 shares (1,190,000 shares for the Family Trust and 510,000 shares for the 2021 Trust) and the underlying shares were pledged to the bank to secure the Holders' obligations thereunder. The Transaction is divided into 10 equal components across each trust, that have expiration dates ranging from June 1, 2029 to June 14, 2029, both inclusive. F9 · derivative.exercise_price: On the relevant expiration date, the call option will automatically be exercised (and the put option will expire unexercised) if the volume weighted average price of the shares of Common Stock on the relevant expiration date (the "Reference Price") is greater than or equal to the call option strike price; the put option will automatically be exercised (and the call option will expire unexercised) if the Reference Price is less than or equal to the put option strike price; and the call option and the put option will each expire unexercised if the Reference Price is greater than the put option strike price but less than the call option strike price. F10 · derivative.exercise_price: For each component, on the applicable settlement date, the applicable Holder will deliver the number of shares corresponding to such component to the bank (or, at such Holder's election, an equivalent amount of cash based on the Reference Price), and receive from the bank an amount of cash (if any) based on the terms of the Transaction. No premium was exchanged for either the call option or the put option. The Holders will be permitted to draw against each component prior to its expiration in accordance with the terms of the Transaction. The Holders generally retained voting and dividend rights over the pledged shares during the term of the pledge, subject to sharing with the bank the economic benefit of any dividends paid during the term of the pledge based on a formula that takes into account a theoretical offsetting position by the bank. F11 · derivative.exercise_price: Exercise price of $60.9986 per share. F8 · kind: On June 12, 2026, the Family Trust and the 2021 Trust (collectively, "Holders") executed revolving loan and collar transactions with an unaffiliated bank (collectively, the "Transaction") for general liquidity purposes, pursuant to which European call options were written and European put options were purchased relating to an aggregate of 1,700,000 shares (1,190,000 shares for the Family Trust and 510,000 shares for the 2021 Trust) and the underlying shares were pledged to the bank to secure the Holders' obligations thereunder. The Transaction is divided into 10 equal components across each trust, that have expiration dates ranging from June 1, 2029 to June 14, 2029, both inclusive. F9 · kind: On the relevant expiration date, the call option will automatically be exercised (and the put option will expire unexercised) if the volume weighted average price of the shares of Common Stock on the relevant expiration date (the "Reference Price") is greater than or equal to the call option strike price; the put option will automatically be exercised (and the call option will expire unexercised) if the Reference Price is less than or equal to the put option strike price; and the call option and the put option will each expire unexercised if the Reference Price is greater than the put option strike price but less than the call option strike price. F10 · kind: For each component, on the applicable settlement date, the applicable Holder will deliver the number of shares corresponding to such component to the bank (or, at such Holder's election, an equivalent amount of cash based on the Reference Price), and receive from the bank an amount of cash (if any) based on the terms of the Transaction. No premium was exchanged for either the call option or the put option. The Holders will be permitted to draw against each component prior to its expiration in accordance with the terms of the Transaction. The Holders generally retained voting and dividend rights over the pledged shares during the term of the pledge, subject to sharing with the bank the economic benefit of any dividends paid during the term of the pledge based on a formula that takes into account a theoretical offsetting position by the bank. F8 · price: On June 12, 2026, the Family Trust and the 2021 Trust (collectively, "Holders") executed revolving loan and collar transactions with an unaffiliated bank (collectively, the "Transaction") for general liquidity purposes, pursuant to which European call options were written and European put options were purchased relating to an aggregate of 1,700,000 shares (1,190,000 shares for the Family Trust and 510,000 shares for the 2021 Trust) and the underlying shares were pledged to the bank to secure the Holders' obligations thereunder. The Transaction is divided into 10 equal components across each trust, that have expiration dates ranging from June 1, 2029 to June 14, 2029, both inclusive. F9 · price: On the relevant expiration date, the call option will automatically be exercised (and the put option will expire unexercised) if the volume weighted average price of the shares of Common Stock on the relevant expiration date (the "Reference Price") is greater than or equal to the call option strike price; the put option will automatically be exercised (and the call option will expire unexercised) if the Reference Price is less than or equal to the put option strike price; and the call option and the put option will each expire unexercised if the Reference Price is greater than the put option strike price but less than the call option strike price. F10 · price: For each component, on the applicable settlement date, the applicable Holder will deliver the number of shares corresponding to such component to the bank (or, at such Holder's election, an equivalent amount of cash based on the Reference Price), and receive from the bank an amount of cash (if any) based on the terms of the Transaction. No premium was exchanged for either the call option or the put option. The Holders will be permitted to draw against each component prior to its expiration in accordance with the terms of the Transaction. The Holders generally retained voting and dividend rights over the pledged shares during the term of the pledge, subject to sharing with the bank the economic benefit of any dividends paid during the term of the pledge based on a formula that takes into account a theoretical offsetting position by the bank. F8 · derivative.exercise_date: On June 12, 2026, the Family Trust and the 2021 Trust (collectively, "Holders") executed revolving loan and collar transactions with an unaffiliated bank (collectively, the "Transaction") for general liquidity purposes, pursuant to which European call options were written and European put options were purchased relating to an aggregate of 1,700,000 shares (1,190,000 shares for the Family Trust and 510,000 shares for the 2021 Trust) and the underlying shares were pledged to the bank to secure the Holders' obligations thereunder. The Transaction is divided into 10 equal components across each trust, that have expiration dates ranging from June 1, 2029 to June 14, 2029, both inclusive. F9 · derivative.exercise_date: On the relevant expiration date, the call option will automatically be exercised (and the put option will expire unexercised) if the volume weighted average price of the shares of Common Stock on the relevant expiration date (the "Reference Price") is greater than or equal to the call option strike price; the put option will automatically be exercised (and the call option will expire unexercised) if the Reference Price is less than or equal to the put option strike price; and the call option and the put option will each expire unexercised if the Reference Price is greater than the put option strike price but less than the call option strike price. F10 · derivative.exercise_date: For each component, on the applicable settlement date, the applicable Holder will deliver the number of shares corresponding to such component to the bank (or, at such Holder's election, an equivalent amount of cash based on the Reference Price), and receive from the bank an amount of cash (if any) based on the terms of the Transaction. No premium was exchanged for either the call option or the put option. The Holders will be permitted to draw against each component prior to its expiration in accordance with the terms of the Transaction. The Holders generally retained voting and dividend rights over the pledged shares during the term of the pledge, subject to sharing with the bank the economic benefit of any dividends paid during the term of the pledge based on a formula that takes into account a theoretical offsetting position by the bank. F8 · derivative.expiration_date: On June 12, 2026, the Family Trust and the 2021 Trust (collectively, "Holders") executed revolving loan and collar transactions with an unaffiliated bank (collectively, the "Transaction") for general liquidity purposes, pursuant to which European call options were written and European put options were purchased relating to an aggregate of 1,700,000 shares (1,190,000 shares for the Family Trust and 510,000 shares for the 2021 Trust) and the underlying shares were pledged to the bank to secure the Holders' obligations thereunder. The Transaction is divided into 10 equal components across each trust, that have expiration dates ranging from June 1, 2029 to June 14, 2029, both inclusive. F9 · derivative.expiration_date: On the relevant expiration date, the call option will automatically be exercised (and the put option will expire unexercised) if the volume weighted average price of the shares of Common Stock on the relevant expiration date (the "Reference Price") is greater than or equal to the call option strike price; the put option will automatically be exercised (and the call option will expire unexercised) if the Reference Price is less than or equal to the put option strike price; and the call option and the put option will each expire unexercised if the Reference Price is greater than the put option strike price but less than the call option strike price. F10 · derivative.expiration_date: For each component, on the applicable settlement date, the applicable Holder will deliver the number of shares corresponding to such component to the bank (or, at such Holder's election, an equivalent amount of cash based on the Reference Price), and receive from the bank an amount of cash (if any) based on the terms of the Transaction. No premium was exchanged for either the call option or the put option. The Holders will be permitted to draw against each component prior to its expiration in accordance with the terms of the Transaction. The Holders generally retained voting and dividend rights over the pledged shares during the term of the pledge, subject to sharing with the bank the economic benefit of any dividends paid during the term of the pledge based on a formula that takes into account a theoretical offsetting position by the bank. F4 · ownership.nature: These securities are held by the Craig F. Courtemanche and Hillary Courtemanche Family Trust dated as of November 1, 2012 ("Family Trust"). F5 · ownership.nature: These securities are held by the Courtemanche 2021 Irrevocable Trust UA DTD 6/10/2021 ("2021 Trust"). Read SEC document |
| June 10, 2026 Filed Jun 13, 2026 01:58 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 56,122 | $2.42 Strike: $2.42 | $135,815.24 |
DisclosureSEC source: 0001805735-26-000004 · form4-06132026_010620.xml · derivative · entry 8 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 224,488 Underlying: Common Stock · 56,122 shares Expires 2026-11-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The shares subject to the option vested in 60 equal monthly installments beginning on the one month anniversary of February 5, 2016, subject to continued service through each applicable vesting date. Read SEC document |
| June 10, 2026 Filed Jun 13, 2026 01:58 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
SaleCommon Stock | 42,421 | $45.29 | $1,921,247.09 |
DisclosureSEC source: 0001805735-26-000004 · form4-06132026_010620.xml · nonDerivative · entry 3 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 919,704 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated December 9, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $45.02 to $45.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 10, 2026 Filed Jun 13, 2026 01:58 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
SaleCommon Stock | 13,701 | $44.69 | $612,297.69 |
DisclosureSEC source: 0001805735-26-000004 · form4-06132026_010620.xml · nonDerivative · entry 2 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 962,125 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated December 9, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $44.01 to $44.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 10, 2026 Filed Jun 13, 2026 01:58 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
Exercise / conversionCommon Stock | 56,122 | $2.42 | $135,815.24 |
DisclosureSEC source: 0001805735-26-000004 · form4-06132026_010620.xml · nonDerivative · entry 1 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 975,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2026 Filed Jun 9, 2026 01:21 UTC |
HOVSEPIAN RONALD WDirector
|
GrantCommon Stock | 2,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041750 · wk-form4_1780968085.xml · nonDerivative · entry 1 HOVSEPIAN RONALD W · CIK 0001091482 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,527 F1 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 100% of the RSUs vest on the date of the issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such annual meeting as a result of the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), subject to the Reporting Person's continued service through such vesting date. Read SEC document |
| June 04, 2026 Filed Jun 9, 2026 01:20 UTC |
O CONNOR KEVIN JDirector
|
GrantCommon Stock | 4,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041747 · wk-form4_1780968011.xml · nonDerivative · entry 1 O CONNOR KEVIN J · CIK 0001106321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,344 F1 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 100% of the RSUs vest on the date of the issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such annual meeting as a result of the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), subject to the Reporting Person's continued service through such vesting date. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is ninety (90) days following the date of termination of service, and (ii) the date of a change in control. Read SEC document |
| June 04, 2026 Filed Jun 9, 2026 01:20 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
GrantCommon Stock | 4,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041748 · wk-form4_1780968034.xml · nonDerivative · entry 1 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 919,704 F1 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 100% of the RSUs vest on the date of the issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such annual meeting as a result of the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), subject to the Reporting Person's continued service through such vesting date. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is ninety (90) days following the date of termination of service, and (ii) the date of a change in control. Read SEC document |
| June 04, 2026 Filed Jun 9, 2026 01:23 UTC |
Bueker KathrynDirector
|
GrantCommon Stock | 4,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041754 · wk-form4_1780968178.xml · nonDerivative · entry 1 Bueker Kathryn · CIK 0001741660 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,193 F1 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 100% of the RSUs vest on the date of the issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such annual meeting as a result of the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), subject to the Reporting Person's continued service through such vesting date. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is ninety (90) days following the date of termination of service, and (ii) the date of a change in control. Read SEC document |
| June 04, 2026 Filed Jun 9, 2026 01:25 UTC |
Griffith William J.G.Director · 10% owner
|
GrantCommon Stock | 4,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-262680 · ownership.xml · nonDerivative · entry 1 Griffith William J.G. · CIK 0001688124 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,249,258 F1 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 100% of the RSUs vest on the date of the issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such annual meeting as a result of the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), subject to the Reporting Person's continued service through such vesting date. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is ninety (90) days following the date of termination of service, and (ii) the date of a change in control. F2 · balance_after: Consists of (i) 4,712 shares issuable upon the settlement of RSUs and (ii) 3,244,546 shares held by the Reporting Person through his family trust of which he is a trustee and another estate planning trust having an independent trustee. The RSUs are held by the Reporting Person, a director of the Issuer. The proceeds of any sale of shares of common stock issued to the Reporting Person upon settlement of the RSUs will be transferred to ICONIQ Capital, LLC. The Reporting Person disclaims beneficial ownership of these shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. F2 · ownership.direct: Consists of (i) 4,712 shares issuable upon the settlement of RSUs and (ii) 3,244,546 shares held by the Reporting Person through his family trust of which he is a trustee and another estate planning trust having an independent trustee. The RSUs are held by the Reporting Person, a director of the Issuer. The proceeds of any sale of shares of common stock issued to the Reporting Person upon settlement of the RSUs will be transferred to ICONIQ Capital, LLC. The Reporting Person disclaims beneficial ownership of these shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| June 04, 2026 Filed Jun 9, 2026 01:20 UTC |
CALDWELL NANCIDirector
|
GrantCommon Stock | 4,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041749 · wk-form4_1780968056.xml · nonDerivative · entry 1 CALDWELL NANCI · CIK 0001232403 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,871 F1 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 100% of the RSUs vest on the date of the issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such annual meeting as a result of the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), subject to the Reporting Person's continued service through such vesting date. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is ninety (90) days following the date of termination of service, and (ii) the date of a change in control. Read SEC document |
| June 04, 2026 Filed Jun 9, 2026 01:23 UTC |
SMITH GRAHAMDirector
|
GrantCommon Stock | 4,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041755 · wk-form4_1780968199.xml · nonDerivative · entry 1 SMITH GRAHAM · CIK 0001219883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,381 F1 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 100% of the RSUs vest on the date of the issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such annual meeting as a result of the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), subject to the Reporting Person's continued service through such vesting date. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is ninety (90) days following the date of termination of service, and (ii) the date of a change in control. Read SEC document |
| June 04, 2026 Filed Jun 9, 2026 01:19 UTC |
Steele ElisaDirector
|
GrantCommon Stock | 4,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041746 · wk-form4_1780967948.xml · nonDerivative · entry 1 Steele Elisa · CIK 0001596281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,871 F1 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 100% of the RSUs vest on the date of the issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such annual meeting as a result of the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), subject to the Reporting Person's continued service through such vesting date. The Reporting Person has elected to defer the receipt of common stock upon the vesting of the RSUs until the earlier of (i) the date that is ninety (90) days following the date of termination of service, and (ii) the date of a change in control. Read SEC document |
| June 04, 2026 Filed Jun 9, 2026 01:22 UTC |
Misra VishalDirector
|
GrantCommon Stock | 603 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041753 · wk-form4_1780968144.xml · nonDerivative · entry 1 Misra Vishal · CIK 0002130674 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,623 F1 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 100% of the RSUs vest on the date of the issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such annual meeting as a result of the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), subject to the Reporting Person's continued service through such vesting date. Read SEC document |
| June 04, 2026 Filed Jun 9, 2026 01:21 UTC |
Chapple ErinDirector
|
GrantCommon Stock | 4,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041752 · wk-form4_1780968110.xml · nonDerivative · entry 1 Chapple Erin · CIK 0001901052 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,555 F1 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 100% of the RSUs vest on the date of the issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such annual meeting as a result of the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election), subject to the Reporting Person's continued service through such vesting date. Read SEC document |
| May 29, 2026 Filed Jun 3, 2026 00:26 UTC |
Singer Benjamin CChief Legal Officer; Secretary
|
SaleCommon Stock | 3,942 | $50.00 | $197,100.00 |
DisclosureSEC source: 0001628280-26-040016 · wk-form4_1780446375.xml · nonDerivative · entry 1 Singer Benjamin C · CIK 0001710257 · Chief Legal Officer; Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,723 F1 · shares: Shares sold pursuant to a 10b5-1 plan dated August 13, 2025. Read SEC document |
| May 20, 2026 Filed May 23, 2026 00:03 UTC |
Davis Steven ScottPresident Product & Technology
|
Tax withholdingCommon Stock | 13,267 | $47.37 | $628,457.79 |
DisclosureSEC source: 0001628280-26-037896 · wk-form4_1779494580.xml · nonDerivative · entry 1 Davis Steven Scott · CIK 0001942011 · President Product & Technology 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,549 F1 · shares: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the Reporting Person upon the vesting of restricted stock units. Read SEC document |
| May 20, 2026 Filed May 23, 2026 00:02 UTC |
Fleming William Fred JrSVP, Corporate Controller
|
Tax withholdingCommon Stock | 1,666 | $47.37 | $78,918.42 |
DisclosureSEC source: 0001628280-26-037894 · wk-form4_1779494527.xml · nonDerivative · entry 1 Fleming William Fred Jr · CIK 0001805695 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,863 F1 · shares: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the Reporting Person upon the vesting of restricted stock units. F2 · balance_after: Includes 331 shares purchased through the Issuer's employee stock purchase plan on May 15, 2026. Read SEC document |
| May 20, 2026 Filed May 23, 2026 00:02 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
Tax withholdingCommon Stock | 12,588 | $47.37 | $596,293.56 |
DisclosureSEC source: 0001628280-26-037895 · wk-form4_1779494552.xml · nonDerivative · entry 1 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 914,992 F1 · shares: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the Reporting Person upon the vesting of restricted stock units. Read SEC document |
| May 20, 2026 Filed May 23, 2026 00:05 UTC |
Gopal AjeiDirector · CEO & President
|
Tax withholdingCommon Stock | 2,986 | $47.37 | $141,446.82 |
DisclosureSEC source: 0001628280-26-037897 · wk-form4_1779494706.xml · nonDerivative · entry 1 Gopal Ajei · CIK 0001302712 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 553,434 F1 · shares: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the Reporting Person upon the vesting of restricted stock units. Read SEC document |
| May 20, 2026 Filed May 23, 2026 00:01 UTC |
Singer Benjamin CChief Legal Officer; Secretary
|
Tax withholdingCommon Stock | 5,849 | $47.37 | $277,067.13 |
DisclosureSEC source: 0001628280-26-037893 · wk-form4_1779494498.xml · nonDerivative · entry 1 Singer Benjamin C · CIK 0001710257 · Chief Legal Officer; Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,665 F1 · shares: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the Reporting Person upon the vesting of restricted stock units. F2 · balance_after: Includes 309 shares purchased through the Issuer's employee stock purchase plan on May 15, 2026. Read SEC document |
| May 11, 2026 Filed May 14, 2026 00:13 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 56,122 | $2.42 Strike: $2.42 | $135,815.24 |
DisclosureSEC source: 0001628280-26-034748 · wk-form4_1778717609.xml · derivative · entry 9 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 280,610 Underlying: Common Stock · 56,122 shares Expires 2026-11-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The shares subject to the option vested in 60 equal monthly installments beginning on the one month anniversary of February 5, 2016, subject to continued service through each applicable vesting date. Read SEC document |
| May 11, 2026 Filed May 14, 2026 00:13 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
SaleCommon Stock | 10,549 | $52.69 | $555,826.81 |
DisclosureSEC source: 0001628280-26-034748 · wk-form4_1778717609.xml · nonDerivative · entry 4 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 927,580 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated December 9, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $52.21 to $53.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2026 Filed May 14, 2026 00:13 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
SaleCommon Stock | 21,287 | $51.16 | $1,089,042.92 |
DisclosureSEC source: 0001628280-26-034748 · wk-form4_1778717609.xml · nonDerivative · entry 3 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 938,129 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated December 9, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $50.83 to $51.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2026 Filed May 14, 2026 00:13 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
SaleCommon Stock | 24,286 | $50.26 | $1,220,614.36 |
DisclosureSEC source: 0001628280-26-034748 · wk-form4_1778717609.xml · nonDerivative · entry 2 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 959,416 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated December 9, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $49.74 to $50.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2026 Filed May 14, 2026 00:13 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
Exercise / conversionCommon Stock | 56,122 | $2.42 | $135,815.24 |
DisclosureSEC source: 0001628280-26-034748 · wk-form4_1778717609.xml · nonDerivative · entry 1 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 983,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2026 Filed Apr 23, 2026 00:07 UTC |
Misra VishalDirector
|
GrantCommon Stock | 10,020 | $0.00 | $0.00 |
DisclosureSEC source: 0002130674-26-000004 · form4-04232026_120407.xml · nonDerivative · entry 1 Misra Vishal · CIK 0002130674 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,020 F1 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). One-third (1/3rd) of the shares underlying the RSUs will vest annually on the anniversary of February 20, 2026 (the "Vesting Commencement Date"), with the first vesting date being February 20, 2027, subject to the Reporting Person's continued service. Read SEC document |
| April 16, 2026 Filed Apr 18, 2026 00:21 UTC |
O CONNOR KEVIN JDirector
|
SaleCommon Stock | 204 | $54.07 | $11,030.28 |
DisclosureSEC source: 0001628280-26-025905 · wk-form4_1776471666.xml · nonDerivative · entry 4 O CONNOR KEVIN J · CIK 0001106321 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 985,214 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated November 21, 2024. F3 · ownership.nature: These shares are held by the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19. Read SEC document |
| April 16, 2026 Filed Apr 18, 2026 00:21 UTC |
O CONNOR KEVIN JDirector
|
SaleCommon Stock | 5,565 | $53.34 | $296,837.10 |
DisclosureSEC source: 0001628280-26-025905 · wk-form4_1776471666.xml · nonDerivative · entry 3 O CONNOR KEVIN J · CIK 0001106321 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 985,418 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated November 21, 2024. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $52.78 to $53.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held by the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19. Read SEC document |
| April 15, 2026 Filed Apr 18, 2026 00:21 UTC |
O CONNOR KEVIN JDirector
|
SaleCommon Stock | 3,239 | $51.42 | $166,549.38 |
DisclosureSEC source: 0001628280-26-025905 · wk-form4_1776471666.xml · nonDerivative · entry 2 O CONNOR KEVIN J · CIK 0001106321 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 990,983 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated November 21, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $51.21 to $51.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held by the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19. Read SEC document |
| April 15, 2026 Filed Apr 18, 2026 00:21 UTC |
O CONNOR KEVIN JDirector
|
SaleCommon Stock | 2,530 | $50.62 | $128,068.60 |
DisclosureSEC source: 0001628280-26-025905 · wk-form4_1776471666.xml · nonDerivative · entry 1 O CONNOR KEVIN J · CIK 0001106321 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 994,222 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated November 21, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $50.15 to $51.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held by the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19. Read SEC document |
| April 10, 2026 Filed Apr 15, 2026 00:46 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 56,122 | $2.42 Strike: $2.42 | $135,815.24 |
DisclosureSEC source: 0001628280-26-025135 · wk-form4_1776214013.xml · derivative · entry 9 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 336,732 Underlying: Common Stock · 56,122 shares Expires 2026-11-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The shares subject to the option vested in 60 equal monthly installments beginning on the one month anniversary of February 5, 2016, subject to continued service through each applicable vesting date. Read SEC document |
| April 10, 2026 Filed Apr 15, 2026 00:46 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
SaleCommon Stock | 2,735 | $49.54 | $135,491.90 |
DisclosureSEC source: 0001628280-26-025135 · wk-form4_1776214013.xml · nonDerivative · entry 4 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 927,580 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated December 9, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $49.12 to $49.745, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2026 Filed Apr 15, 2026 00:46 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
SaleCommon Stock | 4,922 | $48.43 | $238,372.46 |
DisclosureSEC source: 0001628280-26-025135 · wk-form4_1776214013.xml · nonDerivative · entry 3 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 930,315 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated December 9, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $48.08 to $49.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2026 Filed Apr 15, 2026 00:46 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
SaleCommon Stock | 48,465 | $47.45 | $2,299,664.25 |
DisclosureSEC source: 0001628280-26-025135 · wk-form4_1776214013.xml · nonDerivative · entry 2 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 935,237 F1 · kind: These shares sold pursuant to a 10b5-1 plan dated December 9, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $47.08 to $47.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2026 Filed Apr 15, 2026 00:46 UTC |
Courtemanche Craig F. Jr.Director · Chairman of the Board
|
Exercise / conversionCommon Stock | 56,122 | $2.42 | $135,815.24 |
DisclosureSEC source: 0001628280-26-025135 · wk-form4_1776214013.xml · nonDerivative · entry 1 Courtemanche Craig F. Jr. · CIK 0001805735 · Director · Chairman of the Board 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 983,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2026 Filed Apr 3, 2026 00:20 UTC |
Davis Steven ScottPresident Product & Technology
|
GrantCommon Stock | 114,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023444 · wk-form4_1775175611.xml · nonDerivative · entry 1 Davis Steven Scott · CIK 0001942011 · President Product & Technology 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,816 F1 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units (the "RSUs"). One-twelfth (1/12th) of the RSUs vest quarterly on each February 20, May 20, August 20 and November 20 (each, a "Company Vesting Date"), beginning with the first Company Vesting Date following the vesting commencement date of February 20, 2026, and subject to the Reporting Person's continued service through each Company Vesting Date. Read SEC document |
| March 31, 2026 Filed Apr 3, 2026 00:22 UTC |
Fleming William Fred JrSVP, Corporate Controller
|
GrantCommon Stock | 17,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023451 · wk-form4_1775175724.xml · nonDerivative · entry 2 Fleming William Fred Jr · CIK 0001805695 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,198 F2 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units (the "RSUs"). Three-fourths (3/4th) of the shares underlying the RSUs will vest on the first anniversary of May 20, 2026 (the "Vesting Commencement Date"), and one-fourth (1/4th) of the shares underlying the RSUs will vest on the second anniversary of the Vesting Commencement Date. Read SEC document |
| March 31, 2026 Filed Apr 3, 2026 00:22 UTC |
Fleming William Fred JrSVP, Corporate Controller
|
GrantCommon Stock | 19,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023451 · wk-form4_1775175724.xml · nonDerivative · entry 1 Fleming William Fred Jr · CIK 0001805695 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,887 F1 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units (the "RSUs"). One-twelfth (1/12th) of the RSUs vest quarterly on each February 20, May 20, August 20 and November 20 (each, a "Company Vesting Date"), beginning with the first Company Vesting Date following the vesting commencement date of February 20, 2026, and subject to the Reporting Person's continued service through each Company Vesting Date. Read SEC document |
| March 31, 2026 Filed Apr 3, 2026 00:21 UTC |
Gopal AjeiDirector · CEO & President
|
GrantCommon Stock | 147,137 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023448 · wk-form4_1775175677.xml · nonDerivative · entry 1 Gopal Ajei · CIK 0001302712 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 556,420 F1 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units (the "RSUs"). One-twelfth (1/12th) of the RSUs vest quarterly on each February 20, May 20, August 20 and November 20 (each, a "Company Vesting Date"), beginning with the first Company Vesting Date following the vesting commencement date of February 20, 2026, and subject to the Reporting Person's continued service through each Company Vesting Date. Read SEC document |
| March 31, 2026 Filed Apr 3, 2026 00:14 UTC |
Singer Benjamin CChief Legal Officer; Secretary
|
GrantCommon Stock | 41,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023436 · wk-form4_1775175273.xml · nonDerivative · entry 1 Singer Benjamin C · CIK 0001710257 · Chief Legal Officer; Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,205 F1 · shares: Represents shares of common stock issuable upon the settlement of restricted stock units (the "RSUs"). One-twelfth (1/12th) of the RSUs vest quarterly on each February 20, May 20, August 20 and November 20 (each, a "Company Vesting Date"), beginning with the first Company Vesting Date following the vesting commencement date of February 20, 2026, and subject to the Reporting Person's continued service through each Company Vesting Date. Read SEC document |
| March 12, 2026 Filed Mar 17, 2026 00:21 UTC |
Fleming William Fred JrSVP, Corporate Controller
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,500 | $12.22 Strike: $12.22 | $116,090.00 |
DisclosureSEC source: 0001628280-26-018345 · wk-form4_1773706883.xml · derivative · entry 2 Fleming William Fred Jr · CIK 0001805695 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,670 Underlying: Common Stock · 9,500 shares Expires 2028-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4th of the shares subject to the option vested on June 04, 2019 and 1/48th of the shares subject to the option vested monthly thereafter, subject to continued service through each applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.